Relay Therapeutics Statistics

Total Valuation

RLAY has a market cap or net worth of $696.31 million. The enterprise value is -$93.48 million.

Market Cap	696.31M
Enterprise Value	-93.48M

Important Dates

The last earnings date was Wednesday, November 6, 2024, after market close.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

RLAY has 167.38 million shares outstanding. The number of shares has increased by 8.66% in one year.

Current Share Class	167.38M
Shares Outstanding	167.38M
Shares Change (YoY)	+8.66%
Shares Change (QoQ)	+5.58%
Owned by Insiders (%)	1.66%
Owned by Institutions (%)	74.21%
Float	127.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	54.96
Forward PS	2,742.82
PB Ratio	0.83
P/TBV Ratio	0.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 18.42, with a Debt / Equity ratio of 0.06.

Current Ratio	18.42
Quick Ratio	17.88
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -42.69% and return on invested capital (ROIC) is -28.68%.

Return on Equity (ROE)	-42.69%
Return on Assets (ROA)	-26.87%
Return on Capital (ROIC)	-28.68%
Revenue Per Employee	$30,978
Profits Per Employee	-$1.07M
Employee Count	323
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.27% in the last 52 weeks. The beta is 1.59, so RLAY's price volatility has been higher than the market average.

Beta (5Y)	1.59
52-Week Price Change	-61.27%
50-Day Moving Average	5.42
200-Day Moving Average	6.78
Relative Strength Index (RSI)	35.58
Average Volume (20 Days)	2,881,375

Short Selling Information

The latest short interest is 11.93 million, so 7.13% of the outstanding shares have been sold short.

Short Interest	11.93M
Short Previous Month	11.61M
Short % of Shares Out	7.13%
Short % of Float	9.36%
Short Ratio (days to cover)	7.63

Income Statement

In the last 12 months, RLAY had revenue of $10.01 million and -$345.20 million in losses. Loss per share was -$2.61.

Revenue	10.01M
Gross Profit	-314.87M
Operating Income	-394.96M
Pretax Income	-322.83M
Net Income	-345.20M
EBITDA	-389.45M
EBIT	-394.96M
Loss Per Share	-$2.61

Full Income Statement

Balance Sheet

The company has $839.61 million in cash and $49.82 million in debt, giving a net cash position of $789.79 million or $4.72 per share.

Cash & Cash Equivalents	839.61M
Total Debt	49.82M
Net Cash	789.79M
Net Cash Per Share	$4.72
Equity (Book Value)	838.86M
Book Value Per Share	5.03
Working Capital	818.16M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$280.43 million and capital expenditures -$2.14 million, giving a free cash flow of -$282.56 million.

Operating Cash Flow	-280.43M
Capital Expenditures	-2.14M
Free Cash Flow	-282.56M
FCF Per Share	-$1.69

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-3,947.21%
Pretax Margin	-3,449.92%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RLAY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.66%
Shareholder Yield	-8.66%
Earnings Yield	-49.58%
FCF Yield	-40.58%

Dividend Details

Analyst Forecast

The average price target for RLAY is $20.11, which is 383.41% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.11
Price Target Difference	383.41%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	53.62%
EPS Growth Forecast (5Y)	-18.53%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RLAY has an Altman Z-Score of 4.12 and a Piotroski F-Score of 2.

Altman Z-Score	4.12
Piotroski F-Score	2